Latest Articles

Publication Date
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily

Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily

Published: July 16, 2026, 4:40 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork

Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork

Published: July 16, 2026, 3:40 p.m.
Austin Specialists Highlight How Early PCOS and Endometriosis Treatment May Support Fertility Goals - EIN News

Austin Specialists Highlight How Early PCOS and Endometriosis Treatment May Support Fertility Goals EIN News

Published: July 16, 2026, 2:12 p.m.
Endometriosis affects multiple body systems beyond pelvic pain - News-Medical

Endometriosis affects multiple body systems beyond pelvic pain News-Medical

Published: July 16, 2026, 11:19 a.m.
Brazilian doctor flies across the country with a specialized team to bring endometriosis surgeries to women far from major medical centers. - CPG Click Oil and Gas

Brazilian doctor flies across the country with a specialized team to bring endometriosis surgeries to women far from major medical centers. CPG Click Oil and Gas

Published: July 16, 2026, 11:04 a.m.
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Sahm

Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Sahm

Published: July 16, 2026, 10:27 a.m.
Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper - Seoul Economic Daily

Onconic's Nesuparib Targets 26 Trillion Won Endometrial Cancer Market, Backed by SCI Paper Seoul Economic Daily

Published: July 16, 2026, 5:33 a.m.
Symptoms and distress across the menstrual cycle in a representative sample of Austrian and German people who menstruate: A cross-sectional study.

BackgroundPeople who menstruate may experience a range of symptoms, which, fluctuating throughout the different cycle phases, can interfere with their normal functioning. To date, research mostly investigated pain and psychological …

Published: July 16, 2026, midnight
Rheumatic Heart Disease: Inflammation, Immune Pathways, Valve Remodeling, and the Promise of SGLT2 Inhibitors.

Rheumatic heart disease (RHD) remains the leading cause of acquired valvular heart disease in low- and middle-income countries, affecting an estimated 40 million individuals and disproportionately affecting children and young …

Published: July 16, 2026, midnight
Adjunctive vitamin D supplementation in women receiving dienogest therapy for endometriosis: a randomized controlled trial.

Endometriosis is a chronic, estrogen-dependent inflammatory disease that causes debilitating pain and significantly impairs quality of life. Due to its anti-inflammatory and immunomodulatory properties, vitamin D has been proposed as …

Published: July 16, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!